Armata Pharmaceuticals, Inc.
ARMP
$5.64
-$0.35-5.81%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -46.57% | 341.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -46.57% | 341.75% | |||
| Cost of Revenue | 3,387.43% | -96.92% | |||
| Gross Profit | -333.02% | 140.54% | |||
| SG&A Expenses | 18.79% | -19.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.87% | 3.81% | |||
| Operating Income | -13.62% | 16.44% | |||
| Income Before Tax | -63.70% | -149.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -63.70% | -149.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -63.70% | -149.50% | |||
| EBIT | -13.62% | 16.44% | |||
| EBITDA | -14.33% | 17.10% | |||
| EPS Basic | -63.55% | -149.42% | |||
| Normalized Basic EPS | -14.00% | 10.16% | |||
| EPS Diluted | -63.55% | -128.18% | |||
| Normalized Diluted EPS | -14.00% | -47.69% | |||
| Average Basic Shares Outstanding | 0.09% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.09% | -39.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||